A strategic buyer is rumoured to be competing with Thomas H Lee for Maravai Life Science Holdings, the US-listed provider of capping reagents for COVID-19 vaccines.
This is paywall protected Betaville Intelligence content. You need to purchase a subscription to access this content. Or get in touch with subscription sales at [email protected] to find out about the different subscription packages on offer.
